1340 related articles for article (PubMed ID: 24247428)
1. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
[TBL] [Abstract][Full Text] [Related]
2. β-Blocker-Associated Risks in Patients With Uncomplicated Hypertension Undergoing Noncardiac Surgery.
Jørgensen ME; Hlatky MA; Køber L; Sanders RD; Torp-Pedersen C; Gislason GH; Jensen PF; Andersson C
JAMA Intern Med; 2015 Dec; 175(12):1923-31. PubMed ID: 26436291
[TBL] [Abstract][Full Text] [Related]
3. Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery.
London MJ; Hur K; Schwartz GG; Henderson WG
JAMA; 2013 Apr; 309(16):1704-13. PubMed ID: 23613075
[TBL] [Abstract][Full Text] [Related]
4. Time elapsed after ischemic stroke and risk of adverse cardiovascular events and mortality following elective noncardiac surgery.
Jørgensen ME; Torp-Pedersen C; Gislason GH; Jensen PF; Berger SM; Christiansen CB; Overgaard C; Schmiegelow MD; Andersson C
JAMA; 2014 Jul; 312(3):269-77. PubMed ID: 25027142
[TBL] [Abstract][Full Text] [Related]
5. Effect of beta-blocker prescription on the incidence of postoperative myocardial infarction after hip and knee arthroplasty.
van Klei WA; Bryson GL; Yang H; Forster AJ
Anesthesiology; 2009 Oct; 111(4):717-24. PubMed ID: 19707119
[TBL] [Abstract][Full Text] [Related]
6. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
[TBL] [Abstract][Full Text] [Related]
7. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents.
Hawn MT; Graham LA; Richman JS; Itani KM; Henderson WG; Maddox TM
JAMA; 2013 Oct; 310(14):1462-72. PubMed ID: 24101118
[TBL] [Abstract][Full Text] [Related]
8. Preoperative β-blocker use in coronary artery bypass grafting surgery: national database analysis.
Brinkman W; Herbert MA; O'Brien S; Filardo G; Prince S; Dewey T; Magee M; Ryan W; Mack M
JAMA Intern Med; 2014 Aug; 174(8):1320-7. PubMed ID: 24934977
[TBL] [Abstract][Full Text] [Related]
9. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
[TBL] [Abstract][Full Text] [Related]
10. β-Blockade and Operative Mortality in Noncardiac Surgery: Harmful or Helpful?
Friedell ML; Van Way CW; Freyberg RW; Almenoff PL
JAMA Surg; 2015 Jul; 150(7):658-63. PubMed ID: 26017188
[TBL] [Abstract][Full Text] [Related]
11. beta-Blockade in noncardiac surgery: outcome at all levels of cardiac risk.
Kaafarani HM; Atluri PV; Thornby J; Itani KM
Arch Surg; 2008 Oct; 143(10):940-4; discussion 944. PubMed ID: 18936371
[TBL] [Abstract][Full Text] [Related]
12. Heart rate variables in the Vascular Quality Initiative are not reliable predictors of adverse cardiac outcomes or mortality after major elective vascular surgery.
Scali S; Bertges D; Neal D; Patel V; Eldrup-Jorgensen J; Cronenwett J; Beck A
J Vasc Surg; 2015 Sep; 62(3):710-20.e9. PubMed ID: 26067200
[TBL] [Abstract][Full Text] [Related]
13. Perioperative beta-blocker therapy and mortality after major noncardiac surgery.
Lindenauer PK; Pekow P; Wang K; Mamidi DK; Gutierrez B; Benjamin EM
N Engl J Med; 2005 Jul; 353(4):349-61. PubMed ID: 16049209
[TBL] [Abstract][Full Text] [Related]
14. β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial.
Bangalore S; Bhatt DL; Steg PG; Weber MA; Boden WE; Hamm CW; Montalescot G; Hsu A; Fox KA; Lincoff AM
Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):872-81. PubMed ID: 25271049
[TBL] [Abstract][Full Text] [Related]
15. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
[TBL] [Abstract][Full Text] [Related]
16. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
[TBL] [Abstract][Full Text] [Related]
17. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients.
Feringa HH; Bax JJ; Boersma E; Kertai MD; Meij SH; Galal W; Schouten O; Thomson IR; Klootwijk P; van Sambeek MR; Klein J; Poldermans D
Circulation; 2006 Jul; 114(1 Suppl):I344-9. PubMed ID: 16820598
[TBL] [Abstract][Full Text] [Related]
18. Beta-blocker use and clinical outcomes after primary vascular surgery: a nationwide propensity score-matched study.
Høgh A; Lindholt JS; Nielsen H; Jensen LP; Johnsen SP
Eur J Vasc Endovasc Surg; 2013 Jul; 46(1):93-102. PubMed ID: 23660119
[TBL] [Abstract][Full Text] [Related]
19. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
[TBL] [Abstract][Full Text] [Related]
20. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Kim JH; Ahn YK; Jeong MH; Choi DJ; Park JS; Kim YJ; Park HS; Han KR; Rha SW; Gwon HC
JACC Cardiovasc Interv; 2014 Jun; 7(6):592-601. PubMed ID: 24947717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
